|
| Status |
Public on Jun 10, 2014 |
| Title |
ovarian clear cell carcinoma 7 |
| Sample type |
genomic |
| |
|
| Channel 1 |
| Source name |
cancer patient
|
| Organism |
Homo sapiens |
| Characteristics |
disease state: ovarian clear cell carcinoma
age: 36
population (japanese=1, german=0, korean=2): 0
endometriosis (presence=1; absence=0): 0
sensitivity to chemotherapy (sensitive=2; intermediate=1; resistant=0): 0
figo stage: 1
|
| Treatment protocol |
Total DNA by out sorcing
|
| Growth protocol |
Clinical samples
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
0.5 µg of total DNA were primed following manufacturer's instructions
|
| Label |
Cy5
|
| Label protocol |
following manufacturer's instructions
|
| |
|
| Channel 2 |
| Source name |
normal, healthy volunteer
|
| Organism |
Homo sapiens |
| Characteristics |
tissue: peripheral blood
reference composition: human mixed control
|
| Treatment protocol |
Total DNA by out sorcing
|
| Growth protocol |
Clinical samples
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
0.5 µg of total DNA were primed following manufacturer's instructions
|
| Label |
Cy3
|
| Label protocol |
following manufacturer's instructions
|
| |
|
| |
| Hybridization protocol |
Scanned on an Agilent G4449A scanner.
|
| Scan protocol |
Images were quantified using Agilent Feature Extraction Software (version A.8.5.1.1).
|
| Description |
s7
|
| Data processing |
Agilent Feature Extraction Software (v 8.5.1.1) was used for background subtraction and LOWESS normalization.
|
| |
|
| Submission date |
Jun 10, 2014 |
| Last update date |
Jun 10, 2014 |
| Contact name |
Mitsuyoshi Urashima |
| E-mail(s) |
urashima@jikei.ac.jp
|
| Organization name |
Jikei University School of Medicine
|
| Street address |
Nishishimbashi 3-25-8, Minato-ku
|
| City |
Tokyo |
| ZIP/Postal code |
1058461 |
| Country |
Japan |
| |
|
| Platform ID |
GPL9128 |
| Series (1) |
| GSE58342 |
Somatic copy number alterations associated with populations and clinical characteristics in ovarian clear cell adenocarcinoma |
|
